OBI Pharmaceuticals

FDA Approves IND for OBI Pharma's OBI-3424 for a Ph I/II Study in AKR1C3 Solid Tumors
Thu, 04/19/18 - 08:35 am
OBI Pharmaceuticals
OBI-3424
China Biotech In Review: China Starting Up Revamped IPO System
Seeking Alpha
Sun, 01/5/14 - 12:09 pm
China
Stellar Biotechnologies
OBI Pharmaceuticals
Shenzhen Kangtai Biological
Zynex
Chugai
Pfizer